<DOC>
	<DOCNO>NCT02686385</DOCNO>
	<brief_summary>Intervention - Subjects randomize 2 group Group A - subject receive Prednisolone 20 day NAC ( N-Acetylcysteine ) Group B - receive NAC ( N-Acetylcysteine ) NAC ( N-acetylcysteine ) dose Loading dose : 150 mg/kg IV ; mix 200 mL 5 % dextrose water ( D5W ) infuse 1 hour Dose 2 : 50 mg/kg IV 500 mL D5W 4 h Dose 3 : 100 mg/kg IV 1000 mL D5W 16 h - Monitoring assessment-Liver Biopsy baseline 3 month , Liver Function Test regular interval . - Stopping rule-Development sepsis , worsen Liver function .</brief_summary>
	<brief_title>Efficacy N-acetylcysteine With Without Steroids Drug Induced Liver Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>All patient severe DILI ( Drug Induced Liver Injury ) Age equal 18 year Patients HAV ( Hepatitis A Virus ) , HBV ( Hepatitis B Virus ) , HCV ( Hepatitis C Virus ) , HEV ( Hepatitis E Virus ) Positive Patients sepsis AMA positive Low Ceruloplasmin Transferrin saturation &gt; 45 % Patients Cirrhosis Patients h/o jaundice prior intake drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>